vitamin D on the course of pneumonia

Phase 2

• Conditions: Pneumonia.; Influenza and pneumonia; J09, J10,

• Registration Number: IRCT201511023576N3
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

clinical and radiological diagnosis of pneumonia; aged more than 18 years; consent to the entry into the study; able to eat oral vitamin D and placebo. The exclusion criteria: malnutrition; systemic disease; diarrhea; intolerance or sensitivity to vitamin D; recent use of antibiotics.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical signs. Timepoint: At admission, 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Physical examination.

Secondary Outcome Measures

Name	Time	Method
ength of stay in hospital. Timepoint: At discharge. Method of measurement: Review patient records.;Hemodynamic. Timepoint: At admission 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Barometer, thermometer, examination.;Duration of stoping cough and shortness of breath. Timepoint: At admission 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Question from patient.